LSBC Reports Slightly Higher Q1 Revenues; Net Losses Also Up | GenomeWeb

NEW YORK, May 2 - Large Scale Biology reported revenues of $6 million for the first quarter of 2001, up from $5.6 million from the company's first quarter revenues for 2000, the company said Wednesday.

The increase reflects slightly higher revenue from a research contract with Dow Chemical and Dow AgroSciences. The contract accounted for 87 percent of Large Scale Biology's revenue last year, and 88 percent in the first quarter of this year.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: carbapenem resistance in Enterobacteriaceae, selection against educational attainment-linked variants, and more.

Technology Review points out that a new US presidential science advisor hasn't been selected.

Researchers find that blood tests might be able to help determine severity of a concussion, Wired reports.

President-elect Donald Trump considers other candidates for director of the National Institutes of Health, Nature News reports.